Guidelines for the investigation of invasive fungal infections in haematological malignancy and solid organ transplantation

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 16, Issue 6, 1997, Pages 424-436

  Denning, D W ^a   Evans, E G V ^b   Kibbler, C C ^c   Richardson, M D ^d   Roberts, M M ^e   Rogers, T R ^f   Warnock, D W ^g   Warren, R E ^h  

^a NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e HOPE HOSPITAL   (United Kingdom)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g PUBLIC HEALTH ENGLAND   (United Kingdom)

^h ROYAL SHREWSBURY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOMANNAN;

ANTIGEN DETECTION; ASPERGILLOSIS; BLOOD ANALYSIS; BLOOD CULTURE; BONE MARROW TRANSPLANTATION; CANDIDIASIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HEMATOLOGIC DISEASE; HIGH RISK PATIENT; HUMAN; INCUBATION TIME; LUNG LAVAGE; MYCOSIS; NEUTROPENIA; ORGAN TRANSPLANTATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; THORAX RADIOGRAPHY; URINALYSIS;

ALGORITHMS; CENTRAL NERVOUS SYSTEM DISEASES; FEVER OF UNKNOWN ORIGIN; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; LUNG DISEASES, FUNGAL; MYCOSES; NASOPHARYNGEAL DISEASES; NEUTROPENIA; ORGAN TRANSPLANTATION; URINARY TRACT INFECTIONS;

EID: 0030747390     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02471906     Document Type: Review

References (92)

1. Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC: Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clinical Infectious Diseases 1992, 15: 414-421.
2. Schaberg DR, Culver DH, Gaynes RP: Major trends in the microbial etiology of nosocomial infection. American Journal of Medicine 1991, 91 Supplement 3B: 72-75.
3. Groll A, Shah PM, Mentzel CH, Schneider M, Just-Nuebling G, Huebner K: Trends in the postmortem epidemiology of fungal infections in a university hospital. Journal of Infection 1996, 33: 23-32.
4. Bodey G, Bueltmann B, Duguid W, Gibbs D, Hanak H, Hotchi M, Mall G, Martino P, Meunier F, Milliken S, Naoe S, Okudaira M, Scevola D, van't Wout J: Fungal infections in cancer patients - an international autopsy survey. European Journal of Clinical Microbiology & Infectious Diseases 1992, 11: 99-109.
5. DeGregorio MW, Lee WMF, Linker CA, Jacobs RA, Ries CA: Fungal infections in patients with acute leukemia. American Journal of Medicine 1982, 73: 543-548.
6. Meyers JD: Fungal infection in bone marrow transplant patients. Seminars in Oncology 1990, 3: 10-13.
7. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R: Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. New England Journal of Medicine 1991, 325: 1274-1277.
8. Karp JE, Merz WG, Charache P: Response to empiric amphotericin B during antileukemic therapy-induced granulocytopenia. Reviews of Infectious Diseases 1991, 13: 592-599.
9. Murphy JF, McDonald FD, Dawson M, Reite A, Turcotte J, Fekety FR Jr: Factors affecting the frequency of infection in renal transplant recipients. Archives of Internal Medicine 1976, 136: 670-677.
10. Fox BC, Sollinger HW, Beizer FO, Maki DG: A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora and the cost-benefit of prophylaxis. American Journal of Medicine 1990, 89: 255-274.
11. Martinez-Marcos F, Cisneros J, Gentil M, Algarra G, Pereira P, Aznar J, Pachon J: Prospective study of renal transplant infections in 50 consecutive patients, European Journal of Clinical Microbiology & Infectious Diseases 1994, 13: 1023-1028.
12. Grossi P, De Maria R, Caroli A, Zaina MS, Minoli L: Infections in heart transplant recipients: the experience of the Italian heart transplant program. Journal of Heart and Lung Transplantation 1992, 11: 847-866.
13. Hummel M, Thalmann U, Jautzke G, Staib F, Seibold M, Hetzer R: Fungal infections following heart transplantation. Mycoses 1992, 35: 23-34.
14. Kramer MR, Marshall SE, Starnes VA, Gamberg P, Amitai Z, Theodore J: Infectious complications in heart-lung transplantation. Analysis of 200 episodes. Archives of Internal Medicine 1993, 153: 2010-2016.
15. Dummer JS, Montera CG, Griffith BP, Hardesty RL, Paradis IL, Ho M: Infections in heart-lung transplant recipients. Transplantation 1986, 41: 725-729.
16. Kirby RM, McMaster P, Clements D, Hubscher SG, Angrisani L, Sealey M, Gunson BK, Salt PJ, Buckels JA, Adams DH: Orthotopic liver transplantation: postoperative complications and their management. British Journal of Surgery 1987, 74: 3-11.
17. Wajszczuk CP, Dummer JS, Ho M, Van Thiel DH, Starzl TE, Iwatsuki S, Shaw BJ: Fungal infections in liver transplant recipients. Transplantation 1985, 40: 347-353.
18. Kusne S, Dummer JS, Singh N, Iwatsuki S, Makowka L, Esquivel C, Tzakis AG, Starzl TE, Ho M: Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine 1988, 67: 132-143.
19. Viviani MA, Tortorano AM, Malaspina C, Colledan M, Paone G, Rossi G, Bordone G, Pagano A: Surveillance and treatment of liver transplant recipients for candidiasis and aspergillosis. European Journal of Epidemiology 1992, 8: 433-436.
20. Paya CV: Fungal infections in solid-organ transplantation. Clinical Infectious Diseases 1993, 16: 677-688.
21. Horn R, Wong B, Kiehn TE, Armstrong D: Fungemia in a cancer hospital: changing frequency, earlier onset, and result of therapy. Reviews of Infectious Diseases 1985, 7: 646-655.
22. Hopwood V, Warnock DW: New developments in the diagnosis of opportunistic fungal infection. European Journal of Clinical Microbiology 1986, 5: 379-388.
23. Komshian SV, Uwaydah AK, Sobel JD, Crane LR: Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Reviews of Infectious Diseases 1989, 11: 379-390.
24. Jones JM: Laboratory diagnosis of invasive candidiasis. Clinical Microbiology Reviews 1990, 3: 32-45.
25. Guerra-Romero L, Edson RS, Cockerill FR III, Horstmeier CD, Roberts GD: Comparison of Dupont Isolator and Roche Septi-Chek for detection of fungemia. Journal of Clinical Microbiology 1987, 25: 1623-1625.
26. Murray PR: Comparison of the lysis-centrifugation and agitated biphasic blood culture systems for detection of fungemia. Journal of Clinical Microbiology 1991, 29: 96-98.
27. Murray PR, Spizzo AW, Niles AC: Clinical comparison of the recoveries of bloodstream pathogens in Septi-Chek brain heart infusion broth with saponin, Septi-Chek tryptic soy broth, and the Isolator lysis-centrifugation system. Journal of Clinical Microbiology 1991, 29: 901-905.
28. Prevost Smith E, Hutton N: Value of extended agitation and subculture of Bactec NR660 aerobic resin blood culture bottles for clinical yeast isolates. Journal of Clinical Microbiology 1992, 12: 3239-3242.
29. Tarrand JJ, Guillot C, Wenglar M, Jackson J, Lajeunesse JD, Rolston KV: Clinical comparison of the resin-containing Bactec 26 Plus and the Isolator 10 blood culturing systems. Journal of Clinical Microbiology 1991, 29: 2245-2249.
30. Welby PL, Keller DS, Storch GA: Comparison of automated Difco ESP blood culture system with biphasic BBL Septi-Chek system for detection of bloodstream infections in pediatric patients. Journal of Clinical Microbiology 1995, 33: 1084-1088.
31. Rohner P, Pepey B, Auckenthaler R: Comparison of BacT/Alert with Signal blood culture system. Journal of Clinical Microbiology 1995, 33: 313-317.
32. Kirkley BA, Easley KA, Washington JA: Controlled clinical evaluation of Isolator and ESP aerobic blood culture systems for detection of bloodstream infections. Journal of Clinical Microbiology 1994, 32: 1547-1549.
33. Wilson ML, Weinstein MP, Reimer LG, Mirrett S, Reller LB: Controlled comparison of the BacT/Alert and Bactec 660/730 nonradiometric blood culture systems. Journal of Clinical Microbiology 1992, 30: 323-329.
34. Lyon R, Woods G: Comparison of the BacT/Alert and Isolator blood culture systems for recovery of fungi. American Journal of Clinical Pathology 1995, 103: 660-662.
35. Geha DJ, Roberts GD: Laboratory detection of fungemia. Clinical Laboratory Medicine 1994, 14: 83-97.
36. Working Parties of the British Society for Antimicrobial Chemotherapy (BSAC) and the British Society for Medical Mycology (BSMM): Laboratory services for the diagnosis and treatment of fungal infections: a questionnaire survey. Communicable Diseases Review 1996, 6: R69-R75.
37. Pfaller MA: Laboratory aids in the diagnosis of invasive candidiasis. Mycopathologia 1992, 120: 65-72.
38. Shigei JT, Shimabukuro JA, Pezzlo MT, de la Maza LM, Peterson EM: Value of terminal subcultures for blood cultures monitored by Bactec 9240. Journal of Clinical Microbiology 1995, 33: 1385-1388.
39. Martino P, Giremia C, Micozzi A, Raccah R, Gentile G, Venditti M, Mandelli F: Fungemia in patients with leukemia. American Journal of Medical Science 1993, 306: 225-232.
40. Guiot HFL, Fibbe WE, van't Wout JW: Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis. Clinical Infectious Diseases 1994, 18: 525-532.
41. Sandford GR, Merz WG, Wingard JR, Charache P, Saral R: The value of fungal surveillance cultures as predictors of systemic fungal infections. Journal of Infectious Diseases 1980, 142: 503-509.
42. Aisner J, Murillo J, Schimpff SC, Steere AC: Invasive aspergillosis in acute leukemia: correlation with nose cultures and antibiotic use. Annals of Internal Medicine 1979, 90: 4-9.
43. Wiesner RH: The incidence of gram-negative bacterial and fungal infections in liver transplant patients treated with selective decontamination. Infection 1990, 18, Supplement 1: 19-21.
44. Schroter BPJ, Hoelscher M, Putnam CW, Porter KA, Starzl TE: Fungus infections after liver transplantation. Annals of Surgery 1977, 186: 115-122.
45. Trull AK, Parker J, Warren RE: IgG enzyme linked immunosorbent assay for diagnosis of invasive aspergillosis: retrospective study over 15 years of transplant recipients. Journal of Clinical Pathology 1985, 38: 1045-1051.
46. Herent P, Stynen D, Hernando F, Fruit J, Poulain D: Retrospective evaluation of two latex agglutination tests for detection of circulating antigens during invasive candidosis. Journal of Clinical Microbiology 1992, 30: 2158-2164.
47. Pfaller MA, Cabezudo I, Buschelman B, Vitug M, Linton HJ, Densel M: Value of the Hybritech ICON Candida assay in the diagnosis of invasive candidiasis in high risk patients. Diagnostic Microbiology and Infectious Diseases 1993, 16: 53-60.
48. Walsh TJ, Hathorn JW, Sobel JD, Merz WG, Sanchez V, Maret SM, Buckley HR, Pfaller MA, Schaufele R, Sliva C, Navarro E, Lecciones J, Chandrasekar P, Lee J, Pizzo PA: Detection of circulating candida enolase by immunoassay in patients with cancer and invasive candidiasis. New England Journal of Medicine 1991, 324: 1026-1031.
49. Rogers TR, Haynes KA, Barnes RA: Value of antigen detection in predicting invasive pulmonary aspergillosis. Lancet 1990, 336: 1210-1213.
50. Hopwood V, Johnson EM, Cornish JM, Foot AB, Evans EG, Warnock DW: Use of the Pastorex aspergillus antigen latex agglutination test for the diagnosis of invasive aspergillosis. Journal of Clinical Pathology 1995, 48: 210-213.
51. Wong B, Castellanos M: Enantioselective measurement of the Candida metabolite D-arabinitol in human serum using multi-dimensional gas chromatography and a new chiral phase. Journal of Chromatography 1989, 495: 21-30.
52. Roboz J, Yu Q, Holland JF: Filter paper sampling of whole blood and urine for the determination of D/L arabinitol ratios by mass spectrometry. Journal of Microbiology Methods 1992, 15: 207-214.
53. McSharry C, Lewis C, Cruickshank G, Richardson MD: Measurement of serum arabinitol by gas-liquid chromatography - limitations for detection of systemic Candida infections. Journal of Clinical Pathology 1993, 46: 475-476.
54. Switchenko AC, Miyada CG, Goodman TC, Walsh TJ, Wong B, Becker MJ, Ullman EF: An automated enzymatic method for measurement of d-arabinitol, a metabolite of pathogenic Candida species. Journal of Clinical Microbiology 1994, 32: 92-97.
55. Wong B, Brauer KL, Tsai RR, Jayasimhulu K: Increased amounts of the Aspergillus metabolite D-mannitol in tissue and serum of rats with experimental aspergillosis. Journal of Infectious Diseases 1989, 160: 95-103.
56. Megson GM, Law D, Haynes KA, Drucker DB, Ganguli LA, Denning DW: The application of serum mannitol determinations for the diagnosis of invasive pulmonary aspergillosis in bone marrow transplant patients. Journal of Infection 1994, 28, Supplement 1: 58.
57. Thaler M, Pastakia B, Shawker TH, O'Leary T, Pizzo PA: Hepatic candidiasis in cancer patients: the evolving picture of the syndrome. Annals of Internal Medicine 1988, 108: 88-100.
58. Lamminen AE, Anttila VJA, Bondestam S, Ruutu T, Ruutu PJ: Infectious liver foci in leukemia - comparison of short-inversion-time inversion-recovery, t1 -weighted spin-echo, and dynamic gadolinium-enhanced MR imaging. Radiology 1994, 191: 539-543.
59. Graham NJ, Muller NL, Miller RR, Shepherd JD: Intrathoracic complications following allogeneic bone marrow transplantation: CT findings. Radiology 1991, 181: 153-156.
60. Kuhlman JE, Fishman EK, Siegelman SS: Invasive pulmonary aspergillosis in acute leukemia: characteristic findings on CT, the CT halo sign and the role of CT in early diagnosis. Radiology 1985, 157: 611-614.
61. Orr DP, Myerowitz RL, Dubois PJ: Patho-radiologic correlation of invasive pulmonary aspergillosis in the compromised host. Cancer 1978, 41: 2028-2039.
62. Hruban RH, Meziane MA, Zerhouni EA, Wheeler PS, Dumler JS, Hutchins GM: Radiologic-pathologic correlation of the CT halo sign in invasive pulmonary aspergillosis. Journal of Computer Assisted Tomography 1987, 11: 534-536.
63. von Eiff M, Roos N, Schulten R, Hesse M, Zuhlsdorf M, van de Loo J: Pulmonary aspergillosis: early diagnosis improves survival. Respiration 1995, 62: 341-347.
64. Caillot D, Casasnovas O, Bernard A, Couaillier J-F, Durand C, Cuisenier B, Solary E, Piard F, Petrella T, Bonnin A, Couillault G, Dumas M, Guy H: Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. Journal of Clinical Oncology 1997, 15: 139-147.
65. Plunkett MB, Peterson MS, Landreneau RJ, Ferson PF, Posner MC: Peripheral pulmonary nodules: preoperative percutaneous needle localization with CT guidance. Radiology 1992, 185: 274-276.
66. Janzen DL, Adler BD, Padley SPG, Muller NL: Diagnostic success of bronchoscopic biopsy in immunocompromised patients with acute pulmonary disease: predictive value of disease distribution as shown on CT. American Journal of Roentgenology 1993, 160: 21-24.
67. McWhinney PH, Kibbler CC, Hamon MD, Smith OP, Gandhi L, Berger LA, Hoffbrand AV, Prentice HG: Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience. Clinical Infectious Diseases 1993, 17: 397-404.
68. Horvath JA, Dummer S: The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis. American Journal of Medicine 1996, 100: 171-178.
69. Barnes AJ, Denning DW: Aspergilli - significance as pathogens. Reviews in Medical Microbiology 1993, 4: 176-180.
70. Yu VL, Muder RR, Poorsattar A: Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis: results from a three-year prospective study. American Journal of Medicine 1986, 81: 249-254.
71. Treger TR, Visscher DW, Bartlett MS, Smith JW: Diagnosis of pulmonary infection caused by Aspergillus: usefulness of respiratory cultures. Journal of Infectious Diseases 1985, 152: 572-576.
72. Monheit JE, Cowan DF, Moore DG: Rapid detection of fungi in tissues using calcofluor white and fluorescent microscopy. Archives of Pathology and Laboratory Medicine 1984, 108: 616-618.
73. Hollander H, Keilig W, Bauer J, Rothemund E: A reliable fluorescent stain for fungi in tissue sections and clinical specimens. Mycopathologia 1984, 88: 131-134.
74. Milne LJR: Direct microscopy. In: Evans EGV, Richardson MD (ed): Medical microscopy: a practical approach. IRL Press at Oxford University Press, Oxford, 1989, p. 17-45.
75. Yang PC, Chang DB, Yu CJ, Lee YC, Kuo SH, Luh KT: Ultrasound guided percutaneous cutting biopsy for the diagnosis of pulmonary consolidations of unknown aetiology. Thorax 1992, 47: 457-460.
76. Haramati LB: CT-guided automated needle biopsy of the chest. American Journal of Roentgenology 1995, 165: 53-55.
77. Wong K, Waters CM, Walesby RK: Surgical management of invasive pulmonary aspergillosis in immunocompromised patients. European Journal of Cardiothoracic Surgery 1992, 6: 138-142.
78. Denning DW, Stevens DA: Antifungal and surgical treatment of invasive aspergillosis: review of 2, 121 published cases. Reviews of Infectious Diseases 1990, 12: 1147-1201.
79. Talbot GH, Huang A, Provencher M: Invasive Aspergillus rhinosinusitis in patients with acute leukemia. Reviews of Infectious Diseases 1991, 13: 219-232.
80. Morrison VA, Haake RJ, Weisdorf DJ: Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome. American Journal of Medicine 1994, 96: 497-503.
81. Graybill JR: Fungal meningitis. In: Kibbler CC, Mackenzie DWR, Odds FC (ed): Principles and practice of clinical mycology. John Wiley & Sons, Chichester, 1996, p. 81-93.
82. Dismukes WE, Cloud G, Gallis HA, Kerkering TM, Medoff G, Craven PC, Kaplowitz LG, Fisher JF, Gregg CR, Bowles CA (National Institute of Allergy and Infectious Diseases Mycoses Study Group): Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. New England Journal of Medicine 1987, 317: 334-341.
83. Temstet A, Roux P, Poirot JL, Ronin O, Dromer F: Evaluation of a monoclonal antibody-based latex agglutination test for diagnosis of cryptococcosis - comparison with two tests using polyclonal antibodies. Journal of Clinical Microbiology 1992, 30: 2544-2550.
84. Tanner DC, Weinstein MP, Fedorciw B, Joho KL, Thorpe JJ, Reller LB: Comparison of commercial kits for detection of cryptococcal antigen. Journal of Clinical Microbiology 1994, 32: 1680-1684.
85. Kohno S, Yasuoka A, Koga H, Kaku M, Maesaki S, Tanaka K, Mitsutake K, Matsuda H, Hara K: High detection rates of cryptococcal antigen in pulmonary cryptococcosis by Eiken latex agglutination test with pronase pretreatment. Mycopathologia 1993, 123: 75-79.
86. Sekhon AS, Garg AK, Kaufman L, Kobayashi GS, Hamir Z, Jalbert M, Moledina N: Evaluation of a commercial enzyme immunoassay for the detection of cryptococcal antigen. Mycoses 1993, 36: 31-34.
87. Chanock SJ, Toltzis P, Wilson C: Cross-reactivity between Stomatococcus mucilaginosus and latex agglutination for cryptococcal antigen. Lancet 1993, 342: 1119-1120.
88. Westernick MAL, Amsterdam D, Petell RJ, Stram MN, Apicella MA: Septicemia due to DF-2: cause of false positive cryptococcal latex agglutination result. American Journal of Medicine 1987, 83: 155-158.
89. Martinez AJ, Ahdab-Barmada M: The neuropathology of liver transplantation: comparison of main complications in children and adults. Modern Pathology 1993, 6: 25-32.
90. Hagensee ME, Bauwens JE, Kjos B, Bowden RA: Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984-1992. Clinical Infectious Diseases 1994, 19, Supplement 3: 402-408.
91. Argyle C, Schumann GB, Genack L, Gregory M: Identification of fungal casts in a patient with renal candidiasis. Human Pathology 1984, 15: 480-481.
92. Sax PE, Mattia AR, Papanicolaou N, Basgoz N, Semigran MJ: A 55-year-old heart-transplant recipient with a tender, enlarged prostate gland-prostatic abscess, Cryprococcus neoformans. New England Journal of Medicine 1994, 330: 490-496.